These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 21289960)

  • 1. Platelet aggregation inhibitors in primary and secondary prevention of ischemic stroke.
    Gorenoi V; Kulp W; Greiner W; von der Schulenburg JM
    GMS Health Technol Assess; 2006 Apr; 2():Doc09. PubMed ID: 21289960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.
    Jones L; Griffin S; Palmer S; Main C; Orton V; Sculpher M; Sudlow C; Henderson R; Hawkins N; Riemsma R
    Health Technol Assess; 2004 Oct; 8(38):iii-iv, 1-196. PubMed ID: 15461876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet therapy and anticoagulation in patients with hypertension.
    Griffin G
    Am Fam Physician; 2005 Mar; 71(5):897-9. PubMed ID: 15768617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
    Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
    BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet agents and anticoagulants for hypertension.
    Lip GY; Felmeden DC
    Cochrane Database Syst Rev; 2004; (3):CD003186. PubMed ID: 15266473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Incremental cost-effectiveness of dipyridamole + acetylsalicylic acid in secondary prevention of ischemic noncardioembolic stroke].
    Claes C; Mittendorf T; Grond M; von der Schulenburg JM
    Med Klin (Munich); 2008 Nov; 103(11):778-87. PubMed ID: 19165429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylsalicylic acid + extended-release dipyridamole combination therapy for secondary stroke prevention.
    Chaturvedi S
    Clin Ther; 2008 Jul; 30(7):1196-205. PubMed ID: 18691981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and patient safety of platelet aggregation inhibitors in the prevention of cardiovascular disease and ischemic stroke in older adults - a systematic review.
    Meinshausen M; Rieckert A; Renom-Guiteras A; Kröger M; Sommerauer C; Kunnamo I; Martinez YV; Esmail A; Sönnichsen A
    BMC Geriatr; 2017 Oct; 17(Suppl 1):225. PubMed ID: 29047342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and costs of secondary prevention with antiplatelets after ischaemic stroke.
    Ringleb PA; Schwark C; Schwaninger M; Schellinger PD
    Expert Opin Pharmacother; 2005 Mar; 6(3):359-67. PubMed ID: 15794727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The value of platelet inhibitors in the secondary prophylaxis of stroke -- a review].
    Schellinger PD; Jüttler E; Meyding-Lamadé UK; Schwark C
    Fortschr Neurol Psychiatr; 2004 May; 72(5):270-81. PubMed ID: 15136948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
    Algra A; de Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
    Cochrane Database Syst Rev; 2001; (4):CD001342. PubMed ID: 11687110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
    Diener HC; Cunha L; Forbes C; Sivenius J; Smets P; Lowenthal A
    J Neurol Sci; 1996 Nov; 143(1-2):1-13. PubMed ID: 8981292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis.
    Sterne JA; Bodalia PN; Bryden PA; Davies PA; López-López JA; Okoli GN; Thom HH; Caldwell DM; Dias S; Eaton D; Higgins JP; Hollingworth W; Salisbury C; Savović J; Sofat R; Stephens-Boal A; Welton NJ; Hingorani AD
    Health Technol Assess; 2017 Mar; 21(9):1-386. PubMed ID: 28279251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antithrombotic therapy after cerebral ischemia].
    Schellinger PD; Orberk E; Hacke W
    Fortschr Neurol Psychiatr; 1997 Sep; 65(9):425-34. PubMed ID: 9417427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS).
    Diener HC; Sacco R; Yusuf S; ;
    Cerebrovasc Dis; 2007; 23(5-6):368-80. PubMed ID: 17337887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.